DE69806036D1 - 3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden - Google Patents

3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden

Info

Publication number
DE69806036D1
DE69806036D1 DE69806036T DE69806036T DE69806036D1 DE 69806036 D1 DE69806036 D1 DE 69806036D1 DE 69806036 T DE69806036 T DE 69806036T DE 69806036 T DE69806036 T DE 69806036T DE 69806036 D1 DE69806036 D1 DE 69806036D1
Authority
DE
Germany
Prior art keywords
alkyl
optionally substituted
group
hydrogen
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69806036T
Other languages
English (en)
Other versions
DE69806036T2 (de
Inventor
Jean-Francois Patoiseau
Elisabeth Dupont-Passelaigue
Wouter Koek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of DE69806036D1 publication Critical patent/DE69806036D1/de
Application granted granted Critical
Publication of DE69806036T2 publication Critical patent/DE69806036T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69806036T 1997-10-16 1998-10-14 3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden Expired - Lifetime DE69806036T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9712955A FR2769912B1 (fr) 1997-10-16 1997-10-16 Nouveaux derives de la 3-oxo- (2h)-1,2,4 triazine leur preparation et leur application en therapeutique humaine
PCT/FR1998/002205 WO1999020622A1 (fr) 1997-10-16 1998-10-14 Derives de la 3-oxo-2(h)-1,2,4-triazine en tant que ligands des recepteurs 5ht1a

Publications (2)

Publication Number Publication Date
DE69806036D1 true DE69806036D1 (de) 2002-07-18
DE69806036T2 DE69806036T2 (de) 2003-01-30

Family

ID=9512298

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69806036T Expired - Lifetime DE69806036T2 (de) 1997-10-16 1998-10-14 3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden

Country Status (14)

Country Link
US (1) US6303603B1 (de)
EP (1) EP1023287B1 (de)
JP (1) JP4413424B2 (de)
CN (1) CN1128147C (de)
AT (1) ATE219076T1 (de)
AU (1) AU761653B2 (de)
BR (1) BR9812928B1 (de)
CA (1) CA2306428C (de)
DE (1) DE69806036T2 (de)
DK (1) DK1023287T3 (de)
ES (1) ES2177063T3 (de)
FR (1) FR2769912B1 (de)
PT (1) PT1023287E (de)
WO (1) WO1999020622A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030186838A1 (en) * 2000-05-12 2003-10-02 Feenstra Roelof W. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
US7271167B2 (en) * 2002-10-11 2007-09-18 Cytokinetics, Inc. Compounds, compositions, and methods
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
JP2008530229A (ja) * 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
DE4442229A1 (de) * 1994-11-28 1996-05-30 Hoechst Schering Agrevo Gmbh Alkylidenhydrazinophenylsulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren
FR2727682A1 (fr) * 1994-12-02 1996-06-07 Pf Medicament Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament

Also Published As

Publication number Publication date
FR2769912A1 (fr) 1999-04-23
BR9812928B1 (pt) 2013-03-19
JP4413424B2 (ja) 2010-02-10
BR9812928A (pt) 2000-08-08
AU761653B2 (en) 2003-06-05
EP1023287A1 (de) 2000-08-02
EP1023287B1 (de) 2002-06-12
CA2306428A1 (fr) 1999-04-29
DK1023287T3 (da) 2002-10-14
CN1278815A (zh) 2001-01-03
FR2769912B1 (fr) 2000-03-10
ES2177063T3 (es) 2002-12-01
WO1999020622A1 (fr) 1999-04-29
JP2001520226A (ja) 2001-10-30
CN1128147C (zh) 2003-11-19
DE69806036T2 (de) 2003-01-30
PT1023287E (pt) 2002-11-29
AU9545798A (en) 1999-05-10
US6303603B1 (en) 2001-10-16
ATE219076T1 (de) 2002-06-15
CA2306428C (fr) 2010-01-12

Similar Documents

Publication Publication Date Title
YU1900A (sh) Derivati ariloksiarilsulfonilamino hidroksaminske kiseline
CO4970780A1 (es) Nuevos compuestos heterociclicos de piridazina
DK1022272T3 (da) Substituerede, fusionerede, heterocykliske forbindelser
ATE169008T1 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
HUP0202799A2 (hu) Herbicid hatású izoxazolinszármazékok és azt tartalmazó készítmény
DE69332792D1 (de) 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide
DE69918695D1 (de) Sauerstoffhaltige heterocyclische verbindungen
ES395714A1 (es) Procedimiento para la obtencion de derivados de piridoqui- nolina.
DK0947504T3 (da) 16-en-vitamin D-derivater
MX2010010471A (es) Derivado de tetrahidroisoquinolina novedoso.
ATE219076T1 (de) 3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden
FR2702477B1 (fr) Dérivés de benzoxazine, leur préparation et leur application en thérapeutique.
WO2000024717A3 (en) Isoquinoline derivatives
NO955328L (no) Pyridazinon-derivater
BG104309A (en) 8-azabicyclo[3,2,1]octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
DE69915471D1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
TW350843B (en) 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives
NO982549L (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
DK193090A (da) Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf
ATE356805T1 (de) Oxophenylcyclohexylpropanolaminderivate, deren herstellung und verwendung in therapeutika
TW351717B (en) Pyenyl-substituted cyclic ketoenols
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel
HUP0402229A2 (hu) TNF-aktivitású tetrahidropiridil-alkil-heterociklusos vegyületek és ezeket tartalmazó gyógyszerkészítmények
YU28701A (sh) N-(2-(heteroaril)etil)-3-fenilpiperidini, n-(2-(heteroaril) etil)-4-fenilpiperidin i srodna jedinjenja sa supstituentom u položaju 4 piperidinskog prstena

Legal Events

Date Code Title Description
8364 No opposition during term of opposition